Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

NCT00082472 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC

Interventions

DRUG: Doxorubicin HCl Inhalation Solution
DRUG: Docetaxel
DRUG: Cisplatin

Sponsor

Zivena